1'757 companies found
Norgine AG
Lucerne · Since 2005
The core activity of Norgine is the development, manufacture and marketing of pharmaceutical products, in particular specialized medicines in the areas of gastroenterology, hepatology and other specialized therapeutic areas.
NOUSCOM AG
Basel · Since 2015
The core activity of Nouscom is the development of cancer vaccines, in particular neoantigen-based cancer vaccines for tumors with microsatellite instability.
Novartis Bioventures AG
Basel · Since 2017
Novartis Kapital AG
Basel · Since 2024
Novartis Lateinamerika AG
Basel · Since 1981
Novartis International Pharmaceutical Investment AG
Basel · Since 2017
Novartis International Pharmaceutical Investment AG is a pharmaceutical company that develops, manufactures and commercializes medicines and therapies. It conducts research and development across multiple therapeutic areas including cardiovascular, immunology, neuroscience and oncology, and supports manufacturing and distribution of products.
Novartis Overseas Investments AG
Basel · Since 2000
Novartis Pharma AG
Basel · Since 1989
Novartis Pharma AG researches, develops, manufactures and commercializes prescription medicines and therapies. It focuses on therapeutic areas including oncology, neuroscience, immunology and cardiovascular, renal and metabolic diseases, and employs technology platforms such as small‑molecule chemistry, biotherapeutics, RNA‑based approaches, radioligand therapy and gene and cell therapies.
Novartis Sanierungsstiftung
Basel · Since 2008
Novartis Stiftung für Kaderausbildung
Basel · Since 2002
Cactus Life Sciences AG
Meggen · Since 1997
Oculis Operations Sàrl
Lausanne · Since 2022
The core activity of Oculis is the development and research of innovative treatments and medications for eye diseases, particularly in the areas of Diabetic Maculopathy, dry eye, Uveitis and acute Optic Neuritis. The company focuses on developing highly effective and patient-centered solutions to improve the treatment of eye diseases and preserve patients' vision.
Onward Therapeutics SA
Epalinges · Since 2019
The core activity of Onward Therapeutics is the development of innovative cancer treatments, particularly through the identification and development of potential active substances and technologies in the field of immunotherapy and oncology. The company focuses on the development of drugs that support the immune system to fight cancer, and works with partners to develop and market transformative technologies.
Orion Pharma AG
Zug · Since 1978
The core activity of Orion Pharma AG is the development, production and marketing of pharmaceuticals for human and veterinary medicine as well as pharmaceutical excipients.
Panacea Biotec (International) SA
Zug · Since 2009
Pentapharm AG
Aesch Bl · Since 2022
The core activity of Pentapharm is the development and manufacture of innovative solutions for the diagnosis and treatment of coagulation disorders. This includes the production of diagnostic kits and reagents, peptides, enzymes and active pharmaceutical ingredients (APIs) for the pharmaceutical industry. The company focuses on the areas of haemostasis, thrombosis and bleeding and offers products and solutions for the prevention and treatment of coagulation disorders.
Perrigo Schweiz AG
Zurich · Since 1979
PETMedical AG
Steinhausen · Since 2009
Pharmacon AG
Freienbach · Since 2013
Pharmanalytica SA
Locarno · Since 1944
Outbound Leads by COHAGALeadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Discover LeadhubHow the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register